A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered
Medical Journal of Australia, 170 (5), 218-218
The Menopause Society maintains a directory of certified menopause practitioners
When the body doesnt process glucose efficiently, individuals become susceptible to chronic health conditions like high blood pressure and type 2 diabetes, as well as additional weight gain
Glutathione deficiency has been correlated with weaker immune function and increased vulnerability to infection due to the liver's reduced capability to detoxify The biochemical function of glutathione Glutathione two separate forms are available, reduced glutathione (GSH, or L-glutathione), which is an active form, and oxidized glutathione (GSSG), the inactive form
#1 is our top recommendation